Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 11, 2024Сибирский журнал клинической и экспериментальной медициныOpen Access

Epigenetic studies of heart failure confirm clinical and etiological heterogeneity and expand potential diagnostic markers and drug development strategies.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Heart failure significantly decreases patient quality of life, and epigenetics offers a promising approach to examine HF pathogenesis at a new molecular level.

Design

Review

Authors

АКА. Н. КучерМНМ. С. Назаренко

Discussion

Loading...

Member takes

Overview

Epigenetic mechanisms accompany HF development; leaves open their diagnostic or therapeutic utility pending interventional studies.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Кучер et al. (2024) studied this question.

synapsesocial.com/papers/6a7129b184cc45bb7bdfe42dhttps://doi.org/10.29001/2073-8552-2023-38-4-61-69
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epigenetic Modifications the Development of Different Heart Failure Phenotypes2016 · 4 citations
  2. 2Epigenetic signals in heart failure: new opportunities for early diagnosis and eff ective therapy2023
  3. 3Heart Failure: Advanced Development in Genetics and Epigenetics2015 · 52 citations
  4. 4Epigenetics in heart failure phenotypes2016 · 59 citations
  5. 5Epigenetics in Heart Failure: Role of DNA Methylation in Potential Pathways Leading to Heart Failure with Preserved Ejection Fraction2023 · 15 citations